Company intelligence / Profile preview
Biosceptre International
Cambridge, England, United Kingdombiosceptre.com ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Other
01
Overview
Biosceptre has developed a novel immuno-oncology platform targeting the nfP2X7 receptor found on many cancers. Their BRiDGECAR™ system combines this target with multi-specific CAR-T technology and monoclonal antibodies. Past clinical work included a topical agent for non-melanoma skin cancer that showed promising lesion clearance with fewer side effects than competitors in early studies. The company also developed an IHC diagnostic test for prostate cancer risk stratification.
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodyAntibody-drug conjugateChimeric antigen receptor T cell therapy (CAR-T)Diagnostic testTopical therapeutic
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Ongoing collaborations with global experts and major research institutes including University of Sydney
Beyond the preview
Go deeper on Biosceptre International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biosceptre International.